We found that patients who had biochemical recurrence after prostatectomy had significantly lower tumor expression levels of PCA3 (median, 11.58; IQR, 8.28–13.14) than those who did not recur (12.51; 10.64–13.71, [p-value <0.01]; Figure 3D). This evidence concerns the gene PCA3 and neoplasm.